MPM
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate Chemotherapy (NCT01769547) | Ontario Clinical Oncology Group (OCOG) | 2013-03-01 |
Track MPM automatically
Every clearance here is in the API, with alerts when new ones post.